Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - JP
$ 13.62
0.368 %
$ 43.2 B
Market Cap
23.08
P/E
INCOME STATEMENT
4.26 T
REVENUE
214 B
OPERATING INCOME
144 B
NET INCOME
EFFICIENCY
Earnings Waterfall
Takeda Pharmaceutical Company Limited
| Revenue | 4.26 T |
| Cost Of Revenue | 1.94 T |
| Gross Profit | 2.32 T |
| Operating Expenses | 2.62 T |
| Operating Income | 214 B |
| Other Expenses | 70 B |
| Net Income | 144 B |
Income Statement
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 | Mar-2008 | Mar-2007 | Mar-2006 | Mar-2005 | Mar-2004 | Mar-2003 | Mar-2002 | Mar-2001 | Mar-2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||
| Revenue | 4 263 762.0 | 4 027 478.0 | 3 569 006.0 | 3 197 812.0 | 3 291 188.0 | 2 097 224.0 | 1 770 531.0 | 1 732 051.0 | 1 807 378.0 | 1 777 824.0 | 1 691 685.0 | 1 557 267.0 | 1 508 932.0 | 1 419 385.0 | 1 465 965.0 | 1 538 336.0 | 1 374 802.0 | 1 305 167.0 | 1 212 207.0 | 1 122 960.0 | 1 086 431.0 | 1 046 081.0 | 1 005 060.0 | 963 480.0 | 923 132.0 |
| GROSS PROFIT | |||||||||||||||||||||||||
| Cost Of Revenue | 1 942 451.0 | 1 244 072.0 | 1 106 846.0 | 994 308.0 | 1 089 764.0 | 659 690.0 | 495 921.0 | 558 755.0 | 535 405.0 | 520 990.0 | 490 263.0 | 447 628.0 | 433 194.0 | 317 582.0 | 285 064.0 | 289 543.0 | 278 631.0 | 279 662.0 | 282 102.0 | 279 179.0 | 269 395.0 | 300 344.0 | 337 854.0 | 384 013.0 | 432 333.0 |
| Gross Profit | 2 321 311.0 | 2 783 406.0 | 2 462 160.0 | 2 203 504.0 | 2 201 424.0 | 1 437 534.0 | 1 274 610.0 | 1 173 296.0 | 1 271 973.0 | 1 256 834.0 | 1 201 422.0 | 1 109 639.0 | 1 075 738.0 | 1 101 803.0 | 1 180 901.0 | 1 248 793.0 | 1 096 171.0 | 1 025 505.0 | 930 105.0 | 843 781.0 | 817 036.0 | 745 737.0 | 667 206.0 | 579 467.0 | 490 799.0 |
| OPERATING INCOME | |||||||||||||||||||||||||
| Operating Expenses | 2 618 182.0 | 2 292 900.0 | 2 001 315.0 | 1 694 235.0 | 2 101 016.0 | 1 277 169.0 | 1 032 821.0 | 1 017 429.0 | 1 141 145.0 | 1 386 088.0 | 1 062 149.0 | 987 134.0 | 810 711.0 | 734 719.0 | 760 690.0 | 942 325.0 | 673 048.0 | 567 005.0 | 527 296.0 | 458 503.0 | 445 403.0 | 435 051.0 | 385 963.0 | 353 365.0 | 319 356.0 |
| Selling, General and Administrative Expenses | 1 053 819.0 | 997 309.0 | 886 361.0 | 875 663.0 | 964 737.0 | 717 599.0 | 628 106.0 | 619 061.0 | 650 773.0 | 612 613.0 | 556 210.0 | 987 134.0 | 810 711.0 | 734 719.0 | 760 689.0 | 942 325.0 | 0 | 0 | 0 | 0 | 0 | 0 | 385 963.0 | 0 | 319 356.0 |
| Research and Development Expenses | 729 924.0 | 633 325.0 | 526 087.0 | 455 833.0 | 492 381.0 | 368 298.0 | 325 441.0 | 312 303.0 | 345 927.0 | 382 096.0 | 341 560.0 | 324 292.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 214 075.0 | 490 505.0 | 460 844.0 | 509 269.0 | 100 408.0 | 204 969.0 | 241 789.0 | 155 867.0 | 130 828.0 | (129 254.0) | 139 274.0 | 122 505.0 | 265 027.0 | 367 084.0 | 420 211.0 | 306 468.0 | 423 123.0 | 458 500.0 | 402 809.0 | 385 278.0 | 371 633.0 | 310 686.0 | 281 243.0 | 226 102.0 | 171 443.0 |
| PRE-TAX INCOME | |||||||||||||||||||||||||
| Interest Income Expense | 119 535.0 | 169 698.0 | 166 607.0 | 248 631.0 | 165 006.0 | 48 158.0 | 31 928.0 | 23 250.0 | 31 931.0 | 32 878.0 | 30 720.0 | 3 323.0 | 1 883.0 | 1 335.0 | 1 429.0 | 1 621.0 | 333.0 | 247.0 | 365.0 | 334.0 | 359.0 | 420.0 | 759.0 | 1 020.0 | 1 194.0 |
| Total Other Income | (161 284.0) | (115 415.0) | (158 273.0) | (143 034.0) | (161 162.0) | (77 357.0) | (24 584.0) | (12 521.0) | (10 289.0) | (16 183.0) | (1 600.0) | 10 563.0 | (12 549.0) | 4 488.0 | (4 382.0) | 92 078.0 | 153 719.0 | 166 879.0 | 115 148.0 | 55 824.0 | 74 511.0 | 121 212.0 | 92 184.0 | 36 974.0 | 31 321.0 |
| Pre-Tax Income | 52 791.0 | 375 090.0 | 302 571.0 | 366 235.0 | (60 754.0) | 94 896.0 | 217 205.0 | 143 346.0 | 120 539.0 | (145 437.0) | 158 851.0 | 129 707.0 | 252 478.0 | 371 572.0 | 415 829.0 | 398 546.0 | 576 842.0 | 625 379.0 | 517 957.0 | 441 102.0 | 446 144.0 | 431 898.0 | 373 427.0 | 263 076.0 | 202 764.0 |
| NET INCOME | |||||||||||||||||||||||||
| Tax Provision | (91 406.0) | 58 052.0 | 72 405.0 | (9 936.0) | (105 044.0) | (14 118.0) | 30 497.0 | 27 833.0 | 37 059.0 | (2 403.0) | 49 292.0 | (3 880.0) | 125 208.0 | 121 326.0 | 115 668.0 | 161 351.0 | 218 766.0 | 285 844.0 | 201 361.0 | 160 231.0 | 157 911.0 | 157 485.0 | 134 892.0 | 114 148.0 | 81 446.0 |
| Net Income | 144 067.0 | 317 017.0 | 230 059.0 | 376 005.0 | 44 241.0 | 109 126.0 | 186 886.0 | 114 940.0 | 80 166.0 | (145 775.0) | 106 658.0 | 131 244.0 | 124 162.0 | 247 868.0 | 297 744.0 | 234 385.0 | 355 454.0 | 335 805.0 | 313 249.0 | 277 438.0 | 285 264.0 | 271 762.0 | 235 656.0 | 146 855.0 | 119 625.0 |
| EPS | 91.2 | 204 | 147 | 241 | 28.4 | 56.8 | 120 | 73.6 | 51.1 | 92.7 | 67.5 | 94.1 | 78.7 | 157 | 189 | 145 | 209 | 193 | 177 | 157 | 161 | 154 | 134 | 83.2 | 67.8 |